{"pmid":32362005,"title":"Correspondence: Importance of validated serum biochemistry and hemogram parameters for rapid diagnosis and prevent false negative results during COVID-19 pandemic.","text":["Correspondence: Importance of validated serum biochemistry and hemogram parameters for rapid diagnosis and prevent false negative results during COVID-19 pandemic.","COVID-19 threatens millions of lives especially elderly population and people with chronic diseases including diabetes, hypertension, cancer and cardiovascular diseases. Rapid and effective diagnosis are vital for the isolation of infected people and starting treatment immediately to stop the spread of COVID-19 virus. Bioinformatics techniques such as artificial intelligence should be used for collecting the hemogram and serum biochemistry data of all infected people by COVID-19 worldwide even they do not show severe symptoms. These data may be help to find a biomarker which can be used in combination with the CT results for rapid and accurate diagnosis of COVID-19. This article is protected by copyright. All rights reserved.","Biotechnol Appl Biochem","Aydemir, Duygu","Ulusu, Nuriye Nuray","32362005"],"abstract":["COVID-19 threatens millions of lives especially elderly population and people with chronic diseases including diabetes, hypertension, cancer and cardiovascular diseases. Rapid and effective diagnosis are vital for the isolation of infected people and starting treatment immediately to stop the spread of COVID-19 virus. Bioinformatics techniques such as artificial intelligence should be used for collecting the hemogram and serum biochemistry data of all infected people by COVID-19 worldwide even they do not show severe symptoms. These data may be help to find a biomarker which can be used in combination with the CT results for rapid and accurate diagnosis of COVID-19. This article is protected by copyright. All rights reserved."],"journal":"Biotechnol Appl Biochem","authors":["Aydemir, Duygu","Ulusu, Nuriye Nuray"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32362005","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/bab.1936","keywords":["covid-19","artificial intelligence","bioinformatics","hemogram","pandemic","serum biochemical parameters"],"topics":["Diagnosis"],"weight":1,"_version_":1666138495568052226,"score":9.490897,"similar":[{"pmid":32386018,"title":"Value of CT application in the screening,diagnosis,and treatment of COVID-19.","text":["Value of CT application in the screening,diagnosis,and treatment of COVID-19.","The coronavirus disease 2019 (COVID-19) has attracted extensive attention all around the world recently. Early screening, early diagnosis, early isolation, and early treatment remain the most effective prevention and control measures. Computed tomography (CT) plays a vital role in the screening, diagnosis, treatment, and follow-up of COVID-19, especially in the early screening, with a higher sensitivity than that of real-time fluorescence RT-PCR. The combination of CT and artificial intelligence has the potential to help clinicians in improving the diagnostic accuracy and working efficiency.","Zhong Nan Da Xue Xue Bao Yi Xue Ban","Li, Ge","Xiong, Zeng","Zhou, Hui","Xie, Jiangping","Chen, Wei","Zhou, Moling","Zhu, Zhiming","Zhou, Gaofeng","Liu, Jinkang","32386018"],"abstract":["The coronavirus disease 2019 (COVID-19) has attracted extensive attention all around the world recently. Early screening, early diagnosis, early isolation, and early treatment remain the most effective prevention and control measures. Computed tomography (CT) plays a vital role in the screening, diagnosis, treatment, and follow-up of COVID-19, especially in the early screening, with a higher sensitivity than that of real-time fluorescence RT-PCR. The combination of CT and artificial intelligence has the potential to help clinicians in improving the diagnostic accuracy and working efficiency."],"journal":"Zhong Nan Da Xue Xue Bao Yi Xue Ban","authors":["Li, Ge","Xiong, Zeng","Zhou, Hui","Xie, Jiangping","Chen, Wei","Zhou, Moling","Zhu, Zhiming","Zhou, Gaofeng","Liu, Jinkang"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32386018","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.11817/j.issn.1672-7347.2020.200132","keywords":["artificial intelligence","computed tomography","coronavirus disease 2019","diagnosis","follow-up","screening","severe acute respiratory syndrome coronavirus 2"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666340101993529345,"score":155.57918},{"pmid":32367319,"pmcid":"PMC7197034","title":"Artificial intelligence to codify lung CT in Covid-19 patients.","text":["Artificial intelligence to codify lung CT in Covid-19 patients.","The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already assumed pandemic proportions, affecting over 100 countries in few weeks. A global response is needed to prepare health systems worldwide. Covid-19 can be diagnosed both on chest X-ray and on computed tomography (CT). Asymptomatic patients may also have lung lesions on imaging. CT investigation in patients with suspicion Covid-19 pneumonia involves the use of the high-resolution technique (HRCT). Artificial intelligence (AI) software has been employed to facilitate CT diagnosis. AI software must be useful categorizing the disease into different severities, integrating the structured report, prepared according to subjective considerations, with quantitative, objective assessments of the extent of the lesions. In this communication, we present an example of a good tool for the radiologist (Thoracic VCAR software, GE Healthcare, Italy) in Covid-19 diagnosis (Pan et al. in Radiology, 2020. https://doi.org/10.1148/radiol.2020200370). Thoracic VCAR offers quantitative measurements of the lung involvement. Thoracic VCAR can generate a clear, fast and concise report that communicates vital medical information to referring physicians. In the post-processing phase, software, thanks to the help of a colorimetric map, recognizes the ground glass and differentiates it from consolidation and quantifies them as a percentage with respect to the healthy parenchyma. AI software therefore allows to accurately calculate the volume of each of these areas. Therefore, keeping in mind that CT has high diagnostic sensitivity in identifying lesions, but not specific for Covid-19 and similar to other infectious viral diseases, it is mandatory to have an AI software that expresses objective evaluations of the percentage of ventilated lung parenchyma compared to the affected one.","Radiol Med","Belfiore, Maria Paola","Urraro, Fabrizio","Grassi, Roberta","Giacobbe, Giuliana","Patelli, Gianluigi","Cappabianca, Salvatore","Reginelli, Alfonso","32367319"],"abstract":["The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already assumed pandemic proportions, affecting over 100 countries in few weeks. A global response is needed to prepare health systems worldwide. Covid-19 can be diagnosed both on chest X-ray and on computed tomography (CT). Asymptomatic patients may also have lung lesions on imaging. CT investigation in patients with suspicion Covid-19 pneumonia involves the use of the high-resolution technique (HRCT). Artificial intelligence (AI) software has been employed to facilitate CT diagnosis. AI software must be useful categorizing the disease into different severities, integrating the structured report, prepared according to subjective considerations, with quantitative, objective assessments of the extent of the lesions. In this communication, we present an example of a good tool for the radiologist (Thoracic VCAR software, GE Healthcare, Italy) in Covid-19 diagnosis (Pan et al. in Radiology, 2020. https://doi.org/10.1148/radiol.2020200370). Thoracic VCAR offers quantitative measurements of the lung involvement. Thoracic VCAR can generate a clear, fast and concise report that communicates vital medical information to referring physicians. In the post-processing phase, software, thanks to the help of a colorimetric map, recognizes the ground glass and differentiates it from consolidation and quantifies them as a percentage with respect to the healthy parenchyma. AI software therefore allows to accurately calculate the volume of each of these areas. Therefore, keeping in mind that CT has high diagnostic sensitivity in identifying lesions, but not specific for Covid-19 and similar to other infectious viral diseases, it is mandatory to have an AI software that expresses objective evaluations of the percentage of ventilated lung parenchyma compared to the affected one."],"journal":"Radiol Med","authors":["Belfiore, Maria Paola","Urraro, Fabrizio","Grassi, Roberta","Giacobbe, Giuliana","Patelli, Gianluigi","Cappabianca, Salvatore","Reginelli, Alfonso"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32367319","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1007/s11547-020-01195-x","keywords":["artificial intelligence","sars-cov-2","structured report"],"locations":["Thoracic","Italy","Radiology","Thoracic","Thoracic"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1666138496176226304,"score":127.07174},{"pmid":32451808,"title":"Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review.","text":["Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review.","Coronaviruses (CoVs) are a large family of viruses that are common in many animal species, including camels, cattle, cats and bats. Animal CoVs, such as Middle East respiratory syndrome-CoV, severe acute respiratory syndrome (SARS)-CoV, and the new virus named SARS-CoV-2, rarely infect and spread among humans. On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organisation declared the outbreak of the resulting disease from this new CoV called 'COVID-19', as a 'public health emergency of international concern'. This global pandemic has affected almost the whole planet and caused the death of more than 315,131 patients as of the date of this article. In this context, publishers, journals and researchers are urged to research different domains and stop the spread of this deadly virus. The increasing interest in developing artificial intelligence (AI) applications has addressed several medical problems. However, such applications remain insufficient given the high potential threat posed by this virus to global public health. This systematic review addresses automated AI applications based on data mining and machine learning (ML) algorithms for detecting and diagnosing COVID-19. We aimed to obtain an overview of this critical virus, address the limitations of utilising data mining and ML algorithms, and provide the health sector with the benefits of this technique. We used five databases, namely, IEEE Xplore, Web of Science, PubMed, ScienceDirect and Scopus and performed three sequences of search queries between 2010 and 2020. Accurate exclusion criteria and selection strategy were applied to screen the obtained 1305 articles. Only eight articles were fully evaluated and included in this review, and this number only emphasised the insufficiency of research in this important area. After analysing all included studies, the results were distributed following the year of publication and the commonly used data mining and ML algorithms. The results found in all papers were discussed to find the gaps in all reviewed papers. Characteristics, such as motivations, challenges, limitations, recommendations, case studies, and features and classes used, were analysed in detail. This study reviewed the state-of-the-art techniques for CoV prediction algorithms based on data mining and ML assessment. The reliability and acceptability of extracted information and datasets from implemented technologies in the literature were considered. Findings showed that researchers must proceed with insights they gain, focus on identifying solutions for CoV problems, and introduce new improvements. The growing emphasis on data mining and ML techniques in medical fields can provide the right environment for change and improvement.","J Med Syst","Albahri, A S","Hamid, Rula A","Alwan, Jwan K","Al-Qays, Z T","Zaidan, A A","Zaidan, B B","Albahri, A O S","AlAmoodi, A H","Khlaf, Jamal Mawlood","Almahdi, E M","Thabet, Eman","Hadi, Suha M","Mohammed, K I","Alsalem, M A","Al-Obaidi, Jameel R","Madhloom, H T","32451808"],"abstract":["Coronaviruses (CoVs) are a large family of viruses that are common in many animal species, including camels, cattle, cats and bats. Animal CoVs, such as Middle East respiratory syndrome-CoV, severe acute respiratory syndrome (SARS)-CoV, and the new virus named SARS-CoV-2, rarely infect and spread among humans. On January 30, 2020, the International Health Regulations Emergency Committee of the World Health Organisation declared the outbreak of the resulting disease from this new CoV called 'COVID-19', as a 'public health emergency of international concern'. This global pandemic has affected almost the whole planet and caused the death of more than 315,131 patients as of the date of this article. In this context, publishers, journals and researchers are urged to research different domains and stop the spread of this deadly virus. The increasing interest in developing artificial intelligence (AI) applications has addressed several medical problems. However, such applications remain insufficient given the high potential threat posed by this virus to global public health. This systematic review addresses automated AI applications based on data mining and machine learning (ML) algorithms for detecting and diagnosing COVID-19. We aimed to obtain an overview of this critical virus, address the limitations of utilising data mining and ML algorithms, and provide the health sector with the benefits of this technique. We used five databases, namely, IEEE Xplore, Web of Science, PubMed, ScienceDirect and Scopus and performed three sequences of search queries between 2010 and 2020. Accurate exclusion criteria and selection strategy were applied to screen the obtained 1305 articles. Only eight articles were fully evaluated and included in this review, and this number only emphasised the insufficiency of research in this important area. After analysing all included studies, the results were distributed following the year of publication and the commonly used data mining and ML algorithms. The results found in all papers were discussed to find the gaps in all reviewed papers. Characteristics, such as motivations, challenges, limitations, recommendations, case studies, and features and classes used, were analysed in detail. This study reviewed the state-of-the-art techniques for CoV prediction algorithms based on data mining and ML assessment. The reliability and acceptability of extracted information and datasets from implemented technologies in the literature were considered. Findings showed that researchers must proceed with insights they gain, focus on identifying solutions for CoV problems, and introduce new improvements. The growing emphasis on data mining and ML techniques in medical fields can provide the right environment for change and improvement."],"journal":"J Med Syst","authors":["Albahri, A S","Hamid, Rula A","Alwan, Jwan K","Al-Qays, Z T","Zaidan, A A","Zaidan, B B","Albahri, A O S","AlAmoodi, A H","Khlaf, Jamal Mawlood","Almahdi, E M","Thabet, Eman","Hadi, Suha M","Mohammed, K I","Alsalem, M A","Al-Obaidi, Jameel R","Madhloom, H T"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451808","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s10916-020-01582-x","keywords":["artificial intelligence","biological data mining","covid-19","coronaviruses","mers-cov","machine learning","sars-cov-2"],"topics":["Diagnosis"],"weight":1,"_version_":1667881798426689536,"score":126.29639},{"pmid":32413821,"title":"A review of modern technologies for tackling COVID-19 pandemic.","text":["A review of modern technologies for tackling COVID-19 pandemic.","OBJECTIVE: Science and technology sector constituting of data science, machine learning and artificial intelligence are contributing towards COVID-19. The aim of the present study is to discuss the various aspects of modern technology used to fight against COVID-19 crisis at different scales, including medical image processing, disease tracking, prediction outcomes, computational biology and medicines. METHODS: A progressive search of the database related to modern technology towards COVID-19 is made. Further, a brief review is done on the extracted information by assessing the various aspects of modern technologies for tackling COVID-19 pandemic. RESULTS: We provide a window of thoughts on review of the technology advances used to decrease and smother the substantial impact of the outburst. Though different studies relating to modern technology towards COVID-19 have come up, yet there are still constrained applications and contributions of technology in this fight. CONCLUSIONS: On-going progress in the modern technology has contributed in improving people's lives and hence there is a solid conviction that validated research plans including artificial intelligence will be of significant advantage in helping people to fight this infection.","Diabetes Metab Syndr","Kumar, Aishwarya","Gupta, Puneet Kumar","Srivastava, Ankita","32413821"],"abstract":["OBJECTIVE: Science and technology sector constituting of data science, machine learning and artificial intelligence are contributing towards COVID-19. The aim of the present study is to discuss the various aspects of modern technology used to fight against COVID-19 crisis at different scales, including medical image processing, disease tracking, prediction outcomes, computational biology and medicines. METHODS: A progressive search of the database related to modern technology towards COVID-19 is made. Further, a brief review is done on the extracted information by assessing the various aspects of modern technologies for tackling COVID-19 pandemic. RESULTS: We provide a window of thoughts on review of the technology advances used to decrease and smother the substantial impact of the outburst. Though different studies relating to modern technology towards COVID-19 have come up, yet there are still constrained applications and contributions of technology in this fight. CONCLUSIONS: On-going progress in the modern technology has contributed in improving people's lives and hence there is a solid conviction that validated research plans including artificial intelligence will be of significant advantage in helping people to fight this infection."],"journal":"Diabetes Metab Syndr","authors":["Kumar, Aishwarya","Gupta, Puneet Kumar","Srivastava, Ankita"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32413821","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.dsx.2020.05.008","keywords":["artificial intelligence","covid-19","epidemic","machine learning"],"topics":["Prevention","Diagnosis","Mechanism"],"weight":1,"_version_":1666897318931070977,"score":125.330124},{"pmid":32462770,"title":"The Diagnosis of SARS-CoV2 Pneumonia: A Review of Laboratory and Radiological Testing Results.","text":["The Diagnosis of SARS-CoV2 Pneumonia: A Review of Laboratory and Radiological Testing Results.","The rapid emergence of COVID-19 (coronavirus disease 2019) has necessitated the implementation of diverse pandemic control strategies throughout the world. In order to effectively control the spread of this disease, it is essential that it be diagnosed at an early stage so that patients can be reliably quarantined such that disease spread will be slowed. At present, the diagnosis of this infectious form of coronavirus pneumonia is largely dependent upon a combination of laboratory testing and imaging analyses of variable diagnostic efficacy. In the present report, we reviewed prior literature pertaining to the diagnosis of different forms of pneumonia caused by coronaviruses (SARS, MERS, and SARS-CoV-2) and assessed two different potential diagnostic approaches. We ultimately found that computed tomography (CT) was associated with a higher rate of diagnostic accuracy than was a real-time quantitative polymerase chain reaction (qPCR)-based approach (P = 0.0041), and chest radiography (P = 0.0100). Even so, it is important that clinicians utilize a combination of laboratory and radiological testing where possible in order to ensure that this virus is reliably and quickly detected such that it may be treated and patients may be isolated in a timely fashion, thereby effectively curbing the further progression of this pandemic. This article is protected by copyright. All rights reserved.","J Med Virol","Zheng, Zhong","Yao, Zhixian","Wu, Ke","Zheng, Junhua","32462770"],"abstract":["The rapid emergence of COVID-19 (coronavirus disease 2019) has necessitated the implementation of diverse pandemic control strategies throughout the world. In order to effectively control the spread of this disease, it is essential that it be diagnosed at an early stage so that patients can be reliably quarantined such that disease spread will be slowed. At present, the diagnosis of this infectious form of coronavirus pneumonia is largely dependent upon a combination of laboratory testing and imaging analyses of variable diagnostic efficacy. In the present report, we reviewed prior literature pertaining to the diagnosis of different forms of pneumonia caused by coronaviruses (SARS, MERS, and SARS-CoV-2) and assessed two different potential diagnostic approaches. We ultimately found that computed tomography (CT) was associated with a higher rate of diagnostic accuracy than was a real-time quantitative polymerase chain reaction (qPCR)-based approach (P = 0.0041), and chest radiography (P = 0.0100). Even so, it is important that clinicians utilize a combination of laboratory and radiological testing where possible in order to ensure that this virus is reliably and quickly detected such that it may be treated and patients may be isolated in a timely fashion, thereby effectively curbing the further progression of this pandemic. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Zheng, Zhong","Yao, Zhixian","Wu, Ke","Zheng, Junhua"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462770","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26081","keywords":["chest radiography","computed tomography","coronavirus disease 2019","coronavirus pneumonia","diagnosis","polymerase chain reaction"],"topics":["Diagnosis"],"weight":1,"_version_":1668079521264304128,"score":117.14349}]}